Stock VERONA PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Verona Pharma Plc London S.E.

Equities

GB00B06GSH43

End-of-day quote London S.E.
Other stock markets
- GBX - Intraday chart for Verona Pharma Plc
05-09 Verona Pharma Signs Financing Agreements for Up to $650 Million MT
05-09 Verona Pharma Shares Decline After Q1 Loss Widens MT

Chart calendar Verona Pharma Plc

d27f42275256d45.jq_Be1hsvsteV0k95Z1R5u75NGRXTKiTIaqSmUHvISc.2f6IGREzx6E5Yx56sqg4r6fAazUaJdj6TNug4COkakbonPQkIjjQkzoiAA~8f25976548269a0cc94194ee46bf0adf

Upcoming events on Verona Pharma Plc

05/08/2024 Q2 2024 Earnings Release (Projected)
04/11/2024 Q3 2024 Earnings Release (Projected)
26/02/2025 Q4 2024 Earnings Release (Projected)
12/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Verona Pharma Plc

09/05/2024 14:00 Q1 2024 Earnings Call
09/05/2024 07:00 Q1 2024 Earnings Release
29/02/2024 14:00 Q4 2023 Earnings Call
29/02/2024 07:00 Q4 2023 Earnings Release
11/01/2024 00:30 JPMorgan Healthcare Conference
29/11/2023 19:35 Evercore ISI HealthCONx Conference
28/11/2023 13:00 Piper Sandler Healthcare Conference
15/11/2023 15:00 Jefferies London Healthcare Conference
02/11/2023 13:00 Q3 2023 Earnings Call
02/11/2023 07:04 Q3 2023 Earnings Release
18/10/2023 13:00 Business Update Call
09/10/2023 22:00 CHEST Meeting
09/08/2023 17:00 Canaccord Genuity Growth Conference
03/08/2023 14:00 Q2 2023 Earnings Call
03/08/2023 07:00 Q2 2023 Earnings Release
07/06/2023 13:00 Jefferies Global Healthcare Conference
23/05/2023 21:00 American Thoracic Society International Conference
18/05/2023 American Thoracic Society International Conference - Abstract No - P176
18/05/2023 American Thoracic Society International Conference - Abstract No - P175
18/05/2023 American Thoracic Society International Conference - Abstract No - P174

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million GBP		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		30,0
24,6
21.63%		0,38
6,87
-94.46%		0,00
0,00
-
10,8

EBITDA
Million GBP		Released
Forecast
Spread 		-40,6
-35,1
-15.94%		-52,1
-40,9
-27.36%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million GBP		Released
Forecast
Spread 		-41,1
-46,4
11.38%		-52,7
-49,1
-7.28%		-54,9
-64,1
14.25%		-63,0
-56,6
-11.29%		-53,4
-55,7
4.11%
-92,1

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		-39,2
-43,4
9.76%		-46,1
-49,4
6.55%		-41,6
-54,2
23.15%		-56,9
-53,8
-5.73%		-42,6
-48,5
12.12%
-87,7

Net income
Million GBP		Released
Forecast
Spread 		-31,9
-36,5
12.41%		-46,2
-44,8
-3.21%		-41,6
-52,3
20.42%		-57,1
-53,5
-6.82%		-43,0
-49,1
12.54%
-87,8

EPS
USD		Released
Forecast
Spread 		-3,13
-3,43
8.59%		-2,00
-2,03
1.57%		-0,96
-0,88
-8.88%		-1,04
-0,65
-59.18%		-0,09
-0,47
80.97%
-0,69

Announcement Date27/02/2025/02/2103/03/2207/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million GBP		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
2,95
- 		0,38
3,44
-88.92%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


4,21


6,62


14,7

EBIT
Million GBP		Released
Forecast
Spread 		-21,3
-26,0
17.99%		-20,0
-22,7
11.65%		-16,9
-21,2
20.01%		-13,1
-15,3
14.72%		-12,5
-9,92
-26.12%		-17,6
-13,6
-29.7%		-7,84
-17,9
56.22%		-13,5
-18,4
26.83%		-15,1
-15,8
4.73%
-17,4


-22,3


-25,4


-27,0


-19,8

Earnings before Tax (EBT)
Million GBP		Released
Forecast
Spread 		-17,6
-24,2
27.35%		-19,8
-21,1
6.29%		-14,6
-19,0
23.1%		-13,5
-13,4
-0.78%		-8,66
-9,14
5.18%		-13,1
-13,0
-0.97%		-6,69
-17,5
61.72%		-12,1
-17,2
29.93%		-11,2
-15,9
29.43%
-16,2


-21,1


-24,3


-26,2


-18,0

Net income
Million GBP		Released
Forecast
Spread 		-17,4
-23,6
26.11%		-19,9
-21,3
6.61%		-14,7
-18,7
21.72%		-13,5
-13,1
-2.98%		-8,69
-8,87
2.1%		-13,3
-13,3
0.02%		-6,93
-17,8
61.06%		-12,1
-17,5
30.74%		-11,2
-16,0
30.16%
-16,2


-21,1


-24,3


-26,2


-18,0

EPS
USD		Released
Forecast
Spread 		-0,40
-0,35
-15.61%		-0,40
-0,29
-37.93%		-0,32
-0,27
-20%		-0,03
-0,13
76.4%		-0,16
-0,08
-104.26%		-0,24
-0,11
-118.18%		-0,08
-0,21
61.29%		-0,16
-0,03
-392.31%		-0,02
-0,16
87.16%
-0,13


-0,16


-0,21


-0,20


-0,03

Announcement Date03/03/2203/05/2209/08/2209/11/2207/03/2309/05/2303/08/2302/11/2329/02/24-----

Upcoming sector events for Verona Pharma Plc

12/05/2024 PHARMAESSENTIA CORPORATION: Q1 2024 Earnings Release
12/05/2024 ALLOGENE THERAPEUTICS, INC.: Q1 2024 Earnings Release
12/05/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 LEGEND BIOTECH CORPORATION: Q1 2024 Earnings Release
12/05/2024 PEPTRON, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 IMMATICS N.V.: Q1 2024 Earnings Release (Projected)
13/05/2024 SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
13/05/2024 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 PEPTIDREAM INC.: Q1 2024 Earnings Release
13/05/2024 NYKODE THERAPEUTICS: Q1 2024 Earnings Release
More events

Past sector events for Verona Pharma Plc

Today TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected)
09/05/2024 21:01 MACROGENICS, INC.: Q1 2024 Earnings Release
09/05/2024 21:01 ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release
09/05/2024 07:00 VERONA PHARMA PLC: Q1 2024 Earnings Release
09/05/2024 06:00 ARGENX SE: Q1 2024 Earnings Release
08/05/2024 STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 PRIME MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 SAB BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 CABALETTA BIO, INC.: Q1 2024 Earnings Release (Projected)
08/05/2024 ALPINE IMMUNE SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
  1. Stock Market
  2. Equities
  3. VRNA Stock
  4. Stock
  5. Calendar Verona Pharma Plc